TrialBritish journal of cancer2010
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.
A Dufresne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it